Russian fabry patients monitored in new enzyme therapy study

NCT ID NCT06880250

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: NPO Petrovax Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 16, 2026 · Updated 20 times

Summary

This study watches 100 people with Fabry disease who are already receiving enzyme replacement therapy as part of their regular care. Researchers will track changes in key markers like lyso-Gb3 levels, kidney function, and nerve pain over time. The goal is to understand how well the treatment works in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • #10

    Krasnodar, Russia

  • #11

    Ufa, Russia

  • #12

    Ivanovo, Russia

  • #13

    Astrakhan, Russia

  • #15

    Orenburg, Russia

  • #16

    Gubkin, Russia

  • #17

    Omsk, Russia

  • #18

    Kurgan, Russia

  • #19

    Kaa-Khem, Russia

  • #2

    Rostov-on-Don, Russia

  • #21

    Grozny, Russia

  • #22

    Stavropol, Russia

  • #23

    Polevskoy, Russia

  • #24

    Ryazan, Russia

  • #26

    Irkutsk, Russia

  • #27

    Barnaul, Russia

  • #3

    Simferopol, Russia

  • #4

    Rostov-on-Don, Russia

  • #5

    Voronezh, Russia

  • #6

    Chelyabinsk, Russia

  • #7

    Borovichi, Russia

  • #8

    Saint Petersburg, Russia

  • #9

    Perm, Russia

Conditions

Explore the condition pages connected to this study.